Feb 8 |
Best Momentum Stocks to Buy for February 8th
|
Feb 8 |
New Strong Buy Stocks for February 8th
|
Feb 7 |
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
|
Jan 29 |
Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
|
Jan 22 |
Inhibikase Therapeutics, Inc. (IKT) Upgraded to Buy: What Does It Mean for the Stock?
|
Dec 19 |
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
|
Nov 15 |
Inhibikase Therapeutics, Inc. (IKT) Q2 2023 Earnings Call Transcript
|
Nov 14 |
Inhibikase Therapeutics GAAP EPS of -$0.86
|
Nov 14 |
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period Activity
|
Nov 7 |
Correcting & Replacing -- Inhibikase Therapeutics to Report Third Quarter Financial Results on November 14, 2023
|